Many advances have been made to optimize future clinical trials for management of
refractory or resistant CMV infections, and to better understand new resistance mechanisms …

Cytomegalovirus (CMV) continues to be a clinical problem, impairing the overall success
rate of transplantation, either through direct involvement of a variety of end‐organs or by …

The prototype member of the Betaherpesvirinae subfamily, cytomegalovirus (CMV), is the
most important infectious pathogen in transplant recipients, including those receiving bone …

Background Cytomegalovirus (CMV) is a frequent infectious complication following solid
organ transplantation (SOT). Considering significant differences in healthcare systems, a …

ABSTRACT A significant progress has been made in deciphering critical aspects of the
biology and immunology of CMV infection in the allogeneic stem cell transplantation setting …

Objective To assess the rate of, and risk factors for, human cytomegalovirus viremia (HCMV)
in donor+/recipient+ (HCMV serostatus matched) hematopoietic stem-cell transplantation …

Recipients of allogeneic stem cell transplantation (alloSCT) are at risk for reactivation of
endogenous herpesviruses due to profound and prolonged T cell deficiency following …

Purpose This study aimed to describe the cytomegalovirus (CMV) infection rate,
rehospitalizations, and comorbidities following allogeneic hematopoietic stem cell …

Cytomegalovirus (CMV) remains a significant contributor to morbidity and death after
pediatric solid and stem cell transplantation. Decisions regarding prevention and treatment …

Cytomegalovirus (CMV) is a common infection encountered in immunocompromised
patients. It is associated with high morbidity and mortality, particularly in patients undergoing …